Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.1M
-
Number of holders
-
230
-
Total 13F shares, excl. options
-
44.5M
-
Shares change
-
-709K
-
Total reported value, excl. options
-
$2.04B
-
Value change
-
-$24.5M
-
Put/Call ratio
-
0
-
Number of buys
-
77
-
Number of sells
-
-116
-
Price
-
$45.88
Significant Holders of AVANOS MEDICAL, INC. - Common Stock (AVNS) as of Q4 2020
266 filings reported holding AVNS - AVANOS MEDICAL, INC. - Common Stock as of Q4 2020.
AVANOS MEDICAL, INC. - Common Stock (AVNS) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.5M shares
of 46.1M outstanding shares and own 96.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.32M shares), VANGUARD GROUP INC (4.34M shares), WELLINGTON MANAGEMENT GROUP LLP (4.31M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.49M shares), Champlain Investment Partners, LLC (3.47M shares), Paradice Investment Management LLC (2.48M shares), DIMENSIONAL FUND ADVISORS LP (2.21M shares), VICTORY CAPITAL MANAGEMENT INC (2.1M shares), RGM Capital, LLC (1.98M shares), and STATE STREET CORP (1.67M shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.